GeoPolitics Pulse

The Heartbeat of World events

European Commission Approves Astellas’ PADCEV™ (enfortumab vedotin) in Combination …

by ·

PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that the European Commission has …Read More

Related posts:

  1. European Commission Approves Astellas’ PADCEV TM (enfortumab vedotin) in …
  2. Enfortumab vedotin plus pembrolizumab approved in Japan for urothelial carcinoma
  3. Astellas Receives Positive CHMP Opinion for Zolbetuximab in Combination with …
  4. European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Padcev …
  5. Astellas unveils new Japan site for cell therapy research arm – Fierce Biotech